SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 125 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 2.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $18,853,000 | +21.5% | 1,391,369 | +10.4% | 0.00% | 0.0% |
Q3 2016 | $15,513,000 | +17.8% | 1,260,209 | +5.0% | 0.00% | 0.0% |
Q2 2016 | $13,169,000 | -26.1% | 1,200,486 | -26.4% | 0.00% | -25.0% |
Q1 2016 | $17,816,000 | -34.8% | 1,630,036 | +3.1% | 0.00% | -33.3% |
Q4 2015 | $27,346,000 | -15.0% | 1,581,616 | -2.3% | 0.01% | -25.0% |
Q3 2015 | $32,160,000 | +58.7% | 1,618,528 | +31.3% | 0.01% | +60.0% |
Q2 2015 | $20,260,000 | +22.5% | 1,233,093 | +16.0% | 0.01% | +25.0% |
Q1 2015 | $16,542,000 | +12.6% | 1,063,111 | +3.3% | 0.00% | 0.0% |
Q4 2014 | $14,690,000 | +136.7% | 1,028,697 | +7.8% | 0.00% | +100.0% |
Q3 2014 | $6,205,000 | -5.7% | 954,629 | +0.2% | 0.00% | 0.0% |
Q2 2014 | $6,577,000 | +1.1% | 953,191 | +4.7% | 0.00% | 0.0% |
Q1 2014 | $6,507,000 | -19.1% | 910,086 | +6.3% | 0.00% | 0.0% |
Q4 2013 | $8,044,000 | +52.2% | 855,778 | +1.0% | 0.00% | 0.0% |
Q3 2013 | $5,285,000 | +10.5% | 847,031 | +16.5% | 0.00% | 0.0% |
Q2 2013 | $4,784,000 | – | 727,092 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 2,803,138 | $30,835,000 | 9.94% |
Redwood Investments, LLC | 603,176 | $6,635,000 | 0.66% |
ALGERT GLOBAL LLC | 205,529 | $2,261,000 | 0.61% |
Nine Chapters Capital Management LLC | 40,500 | $446,000 | 0.60% |
Malaga Cove Capital, LLC | 84,269 | $897,000 | 0.54% |
CLARK ESTATES INC/NY | 250,000 | $2,750,000 | 0.42% |
AlphaMark Advisors, LLC | 78,500 | $864,000 | 0.40% |
Ativo Capital Management LLC | 109,023 | $1,199,000 | 0.30% |
GLOBEFLEX CAPITAL L P | 103,949 | $1,143,000 | 0.27% |
Piermont Capital Management Inc. | 65,959 | $726,000 | 0.17% |